
Hematology Diagnostics Market Size, Share, and Analysis, By Product (Instrument, Consumables), By Test (Anemia, Hemoglobinopathy, Leukemia/Lymphoma Phenotyping, Hematology Pathophysiology, Complete Blood Count (CBC), and Others), By End User (Hospitals &
Description
Hematology Diagnostics Market Size, Share, and Analysis, By Product (Instrument, Consumables), By Test (Anemia, Hemoglobinopathy, Leukemia/Lymphoma Phenotyping, Hematology Pathophysiology, Complete Blood Count (CBC), and Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes) and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034
PRODUCT OVERVIEW
Hematology Diagnostics Market, valued at USD 4.5 billion in 2023, is anticipated to grow at a steady CAGR of 5.1% from 2024 to 2034, reaching a projected market size of USD 7.8 billion by the end of the forecast period.
Hematology diagnostics involves the examination and analysis of blood and its components to diagnose a wide range of diseases and disorders. Utilizing advanced technologies such as hematology analyzers, flow cytometers, and cell counters, this field focuses on assessing blood cells, hemoglobin levels, hematocrit, and other vital parameters. These tools are crucial for diagnosing conditions like anemia, infections, clotting disorders, and blood cancers like leukemia. Recent technological advancements in hematology diagnostics, including automated high-throughput testing systems and integration with laboratory information systems, have significantly enhanced the precision, efficiency, and speed of diagnostic processes, leading to improved patient care through timely and accurate diagnosis.
MARKET HIGHLIGHTS
Hematology Diagnostics Market is expected to reach USD 7.8 billion, with a 5.1% CAGR. This growth is driven by the rising incidence of blood disorders, such as anemia, leukemia, and hemophilia, particularly among the aging population. The market is also benefiting from advancements in diagnostic technologies, such as automated and point-of-care systems, which improve both efficiency and accuracy. Additionally, increased healthcare spending and expanded access to diagnostic services in emerging economies are contributing to market expansion. Continued growth is expected as technological advancements, partnerships, and R&D efforts address the evolving needs of healthcare professionals and patients.
Hematology Diagnostics Market Segments:
Growth Drivers
Increasing Prevalence of Blood Disorders to Fuel Demand for Hematology Diagnostic Tests
Development of Advanced Hematology Analyzers and Kits to Drive Market Growth
Restraint
High Costs of Advanced Equipment Pose a Significant Challenge for Market Growth
Key Players
PRODUCT OVERVIEW
Hematology Diagnostics Market, valued at USD 4.5 billion in 2023, is anticipated to grow at a steady CAGR of 5.1% from 2024 to 2034, reaching a projected market size of USD 7.8 billion by the end of the forecast period.
Hematology diagnostics involves the examination and analysis of blood and its components to diagnose a wide range of diseases and disorders. Utilizing advanced technologies such as hematology analyzers, flow cytometers, and cell counters, this field focuses on assessing blood cells, hemoglobin levels, hematocrit, and other vital parameters. These tools are crucial for diagnosing conditions like anemia, infections, clotting disorders, and blood cancers like leukemia. Recent technological advancements in hematology diagnostics, including automated high-throughput testing systems and integration with laboratory information systems, have significantly enhanced the precision, efficiency, and speed of diagnostic processes, leading to improved patient care through timely and accurate diagnosis.
MARKET HIGHLIGHTS
Hematology Diagnostics Market is expected to reach USD 7.8 billion, with a 5.1% CAGR. This growth is driven by the rising incidence of blood disorders, such as anemia, leukemia, and hemophilia, particularly among the aging population. The market is also benefiting from advancements in diagnostic technologies, such as automated and point-of-care systems, which improve both efficiency and accuracy. Additionally, increased healthcare spending and expanded access to diagnostic services in emerging economies are contributing to market expansion. Continued growth is expected as technological advancements, partnerships, and R&D efforts address the evolving needs of healthcare professionals and patients.
Hematology Diagnostics Market Segments:
- By Product
- Instrument
- Analyzers
- Fully automated
- Semi-automated
- Flow Cytometers
- Consumables
- Reagents
- Stains
- Controls & Calibrators
- By Test
- Anemia
- Hemoglobinopathy
- Leukemia/Lymphoma Phenotyping
- Hematology Pathophysiology
- Complete Blood Count (CBC)
- Others
- By End-User
- Hospitals & Clinics
- Diagnostic Laboratories
- Academic & Research Institutes
Growth Drivers
Increasing Prevalence of Blood Disorders to Fuel Demand for Hematology Diagnostic Tests
Development of Advanced Hematology Analyzers and Kits to Drive Market Growth
Restraint
High Costs of Advanced Equipment Pose a Significant Challenge for Market Growth
Key Players
- Sysmex Corporation
- Danaher Corporation
- Abbott Laboratories
- Siemens
- Bio-Rad Laboratories, Inc.
- Mindray Medical International Limited
- HORIBA, Ltd.
- Nihon Kohden Corporation
- Boule Diagnostics AB
- EKF Diagnostics
- Ortho Clinical Diagnostics
- Beckman Coulter, Inc.
- Shenzhen New Industries Biomedical Engineering Co., Ltd. (Snibe)
- Diatron
- Sysmex Partec GmbH
- Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
Table of Contents
565 Pages
- 1. Executive Summary
- 1.1. Regional Market Share
- 1.2. Business Trends
- 1.3. Hematology Diagnostics Market: COVID-19 Outbreak
- 1.4. Regional Trends
- 1.5. Segmentation Snapshot
- 2. Research Methodology
- 2.1. Research Objective
- 2.2. Research Approach
- 2.3. Data Sourcing and Methodology
- 2.4. Primary Research
- 2.5. Secondary Research
- 2.5.1. Paid Sources
- 2.5.2. Public Sources
- 2.6. Market Size Estimation and Data Triangulation
- 3. Market Characteristics
- 3.1. Market Definition
- 3.2. Hematology Diagnostics Market: COVID-19 Impact
- 3.3. Key Segmentations
- 3.4. Key Developments
- 3.5. Allied Industry Data
- 4. Hematology Diagnostics Market – Industry Insights
- 4.1. Industry Segmentation
- 4.2. COVID-19 overview on world economy
- 4.3. Industry ecosystem Channel analysis
- 4.4. Innovation & Sustainability
- 5. Macroeconomic Indicators
- 6. Recent Developments
- 7. Market Dynamics
- 7.1. Introduction
- 7.2. Growth Drivers
- 7.3. Market Opportunities
- 7.4. Market Restraints
- 7.5. Market Trends
- 8. Risk Analysis
- 9. Market Analysis
- 9.1. Porters Five Forces
- 9.2. PEST Analysis
- 9.2.1. Political
- 9.2.2. Economic
- 9.2.3. Social
- 9.2.4. Technological
- 10. Hematology Diagnostics Market
- 10.1. Overview
- 10.2. Historical Analysis (2019-2022)
- 10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
- 11. Hematology Diagnostics Market Size & Forecast 2024 A-2034 F
- 11.1. Overview
- 11.2. Key Findings
- 11.3. Market Segmentation
- 11.3.1. By Product
- 11.3.1.1. Instrument
- 11.3.1.1.1. Analyzers
- 11.3.1.1.1.1. Fully automated
- 11.3.1.1.1.1.1. By Value (USD Million) 2024-2034 F
- 11.3.1.1.1.1.2. Market Share (%) 2024-2034 F
- 11.3.1.1.1.1.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.1.1.1.2. Semi-Automated
- 11.3.1.1.1.2.1. By Value (USD Million) 2024-2034 F
- 11.3.1.1.1.2.2. Market Share (%) 2024-2034 F
- 11.3.1.1.1.2.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.1.2. Consumables
- 11.3.1.2.1. Reagents
- 11.3.1.2.1.1. By Value (USD Million) 2024-2034 F
- 11.3.1.2.1.2. Market Share (%) 2024-2034 F
- 11.3.1.2.1.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.1.2.2. Stains
- 11.3.1.2.2.1. By Value (USD Million) 2024-2034 F
- 11.3.1.2.2.2. Market Share (%) 2024-2034 F
- 11.3.1.2.2.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.1.2.3. Controls & Calibrators
- 11.3.1.2.3.1. By Value (USD Million) 2024-2034 F
- 11.3.1.2.3.2. Market Share (%) 2024-2034 F
- 11.3.1.2.3.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2. By Test
- 11.3.2.1. Anemia
- 11.3.2.1.1. By Value (USD Million) 2024-2034 F
- 11.3.2.1.2. Market Share (%) 2024-2034 F
- 11.3.2.1.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2.2. Hemoglobinopathy
- 11.3.2.2.1. By Value (USD Million) 2024-2034 F
- 11.3.2.2.2. Market Share (%) 2024-2034 F
- 11.3.2.2.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2.3. Leukemia/Lymphoma Phenotyping
- 11.3.2.3.1. By Value (USD Million) 2024-2034 F
- 11.3.2.3.2. Market Share (%) 2024-2034 F
- 11.3.2.3.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2.4. Hematology Pathophysiology
- 11.3.2.4.1. By Value (USD Million) 2024-2034 F
- 11.3.2.4.2. Market Share (%) 2024-2034 F
- 11.3.2.4.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2.5. Complete Blood Count (CBC)
- 11.3.2.5.1. By Value (USD Million) 2024-2034 F
- 11.3.2.5.2. Market Share (%) 2024-2034 F
- 11.3.2.5.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2.6. Others
- 11.3.2.6.1. By Value (USD Million) 2024-2034 F
- 11.3.2.6.2. Market Share (%) 2024-2034 F
- 11.3.2.6.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.3. By End-User
- 11.3.3.1. Hospitals & Clinics
- 11.3.3.1.1. By Value (USD Million) 2024-2034 F
- 11.3.3.1.2. Market Share (%) 2024-2034 F
- 11.3.3.1.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.3.2. Diagnostics Laboratories
- 11.3.3.2.1. By Value (USD Million) 2024-2034 F
- 11.3.3.2.2. Market Share (%) 2024-2034 F
- 11.3.3.2.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.3.3. Academic & Research Institutes
- 11.3.3.3.1. By Value (USD Million) 2024-2034 F
- 11.3.3.3.2. Market Share (%) 2024-2034 F
- 11.3.3.3.3. Y-o-Y Growth (%) 2024-2034 F
- 12. North America Hematology Diagnostics Market Size & Forecast 2024 A-2034 F
- 12.1. Overview
- 12.2. Key Findings
- 12.3. Market Segmentation
- 12.3.1. By Product
- 12.3.2. By Test
- 12.3.3. By End-User
- 12.4. Country
- 12.4.1. United States
- 12.4.2. Canada
- 13. Europe Hematology Diagnostics Market Size & Forecast 2024 A-2034 F
- 13.1. Overview
- 13.2. Key Findings
- 13.3. Market Segmentation
- 13.3.1. By Product
- 13.3.2. By Test
- 13.3.3. By End-User
- 13.4. Country
- 13.4.1. Germany
- 13.4.2. United Kingdom
- 13.4.3. France
- 13.4.4. Italy
- 13.4.5. Spain
- 13.4.6. Russia
- 13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
- 14. Asia-Pacific Hematology Diagnostics Market Size & Forecast 2024 A-2034 F
- 14.1. Overview
- 14.2. Key Findings
- 14.3. Market Segmentation
- 14.3.1. By Product
- 14.3.2. By Test
- 14.3.3. By End-User
- 14.4. Country
- 14.4.1. India
- 14.4.2. China
- 14.4.3. South Korea
- 14.4.4. Japan
- 14.4.5. Rest of APAC
- 15. Middle East and Africa Hematology Diagnostics Market Size & Forecast 2024 A-2034 F
- 15.1. Overview
- 15.2. Key Findings
- 15.3. Market Segmentation
- 15.3.1. By Product
- 15.3.2. By Test
- 15.3.3. By End-User
- 15.4. Country
- 15.4.1. Israel
- 15.4.2. GCC
- 15.4.3. North Africa
- 15.4.4. South Africa
- 15.4.5. Rest of Middle East and Africa
- 16. Latin America Hematology Diagnostics Market Size & Forecast 2024 A-2034 F
- 16.1. Overview
- 16.2. Key Findings
- 16.3. Market Segmentation
- 16.3.1. By Product
- 16.3.2. By Test
- 16.3.3. By End-User
- 16.4. Country
- 16.4.1. Mexico
- 16.4.2. Brazil
- 16.4.3. Rest of Latin America
- 17. Competitive Landscape
- 17.1. Company market share, 2023
- 17.2. Key player overview
- 17.3. Key stakeholders
- 18. Company Profiles
- 18.1. Sysmex Corporation
- 18.1.1. Company Overview
- 18.1.2. Financial Overview
- 18.1.3. Key Product; Analysis
- 18.1.4. Company Assessment
- 18.1.4.1. Product Portfolio
- 18.1.4.2. Key Clients
- 18.1.4.3. Market Share
- 18.1.4.4. Recent News & Development (Last 3 Yrs.)
- 18.1.4.5. Executive Team
- 18.2. Danaher Corporation
- 18.3. Abbott Laboratories
- 18.4. Siemens
- 18.5. Bio-Rad Laboratories, Inc.
- 18.6. Mindray Medical International Limited
- 18.7. HORIBA, Ltd.
- 18.8. Nihon Kohden Corporation
- 18.9. Boule Diagnostics AB
- 18.10. EKF Diagnostics
- 18.11. Ortho Clinical Diagnostics
- 18.12. Beckman Coulter, Inc.
- 18.13. Shenzhen New Industries Biomedical Engineering Co., Ltd. (Snibe)
- 18.14. Diatron
- 18.15. Sysmex Partec GmbH
- 18.16. Other Prominent Players
- 19. Appendix
- 20. Consultant Recommendation
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.